Lark Funding, Investors & Competitors

Noom is a digital health platform combining psychology, AI, and human coaching for wellness goals including weight management, diabetes prevention, and stress reduction. New York City-headquartered, it secured grants from the National Institutes of Health and became the first mobile app certified by the Centers for Disease Control for diabetes prevention. Noom serves millions via app-based programs with behavioral tracking and virtual coaching sessions. Recognized by Inc and Fortune for workplace culture, it operates globally with personalized nutrition and habit-building modules.

Cult.fit is a Bangalore-headquartered health and fitness company founded in 2016. It operates over 280 gyms across 50 Indian cities, delivering trainer-led classes in yoga, dance, strength training, and cycling. The platform provides nutrition plans via EatFit cloud kitchens, mental wellness through Cult.Mind, and primary care consultations, serving 2 million monthly active users.

Twin Health is a Mountain View, California-headquartered digital health company offering an AI-driven Whole Body Digital Twin platform for metabolic disorders. The system uses wearable sensors to monitor glucose, activity, and sleep, generating personalized nutrition and lifestyle plans. Clinically validated to reverse type 2 diabetes, Twin Health operates clinics in the US and India.

Welle is a digital health company based in New York providing personalized care plans to mitigate inflammation and chronic disease risks. Its platform uses at-home testing kits for biomarkers like hsCRP and offers nutrition, supplement, and lifestyle recommendations via app-based coaching. Welle targets corporate wellness programs and partners with employers in finance and tech sectors for employee health initiatives.

Evidation Health is a San Mateo-headquartered company founded in 2012 that measures health outcomes through everyday activities via its Achievement platform. The platform enables participation in research and health programs with partners in healthcare and pharmaceuticals. Evidation maintains offices worldwide and emphasizes user-controlled health data for studies beyond clinical settings.

Glooko is a Mountain View-headquartered remote patient monitoring platform for diabetes management. It syncs data from devices like Dexcom G7, Omnipod pumps, and Fitbit trackers into a cloud dashboard for clinicians. Available on iOS and Android, Glooko generates reports shared via telehealth. Launched in 2010, it supports 4 million users and partners with insurers like UnitedHealthcare.

Viome is a Bellevue-headquartered precision health company analyzing microbiome, mitochondrial, and cellular data through at-home test kits. Established in 2016, it provides personalized nutrition and lifestyle recommendations based on RNA sequencing of gut, oral, and cellular samples. The platform tracks biological age and health metrics for users seeking optimized wellness plans.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

TALI Digital Ltd engaged in research and development, for commercialization, of medical technology projects. It is a digital health company delivering diagnostic and therapeutic solutions to improve cognitive function and behavior.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity’s products and services are sold worldwide, with major markets in the US, Europe, and China.

In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon’s services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

OpenEvidence is a New York-based AI platform synthesizing peer-reviewed medical literature and journal content to deliver evidence-based answers for clinicians. It scans millions of studies for treatment recommendations, diagnostics, and guidelines, partnering with JAMA and NEJM. Launched in 2023, the tool supports bedside decision-making with cited sources and update alerts.

Oura is a Helsinki-headquartered company founded in 2013 that manufactures the Oura Ring Gen3, a finger-worn sensor tracking heart rate, blood oxygen, temperature, and sleep stages. The companion app delivers readiness, activity, and recovery scores used by professional athletes and over 10 million app downloads worldwide. Available in the US, Europe, and Asia through direct sales and retailers like Best Buy.

Neko Health is a Stockholm-based preventive healthcare company that offers full-body health scans to people who are not ill. It was co-founded by Daniel Ek, the founder of Spotify, and Hjalmar Nilsonne. A member visits a clinic for a short scan that combines body imaging, sensors and blood analysis to look for skin cancer, metabolic risk, prediabetes and cardiovascular risk factors. The company builds its own scanning devices and data science models and runs its own clinics, where results are explained to members through an app. Customers are individual consumers who pay per scan or through membership, and the company has expanded from Sweden to the United Kingdom and other European markets. It earns revenue from scan and clinic fees and from follow-up care services. The company was seeded by Prima Materia, the investment firm Ek co-founded.